borderline significancep = 0.066
This association was at a borderline significance in HER2-positive [75.0% (3/4) vs. 12.5% (1/8), p = 0.066] cancer and not significant in luminal A [22.7% (5/22) vs. 10.0% (3/30), p = 0.259], luminal B [21.1% (4/19) vs. 6.7% (2/30), p = 0.189], and triple-negative [40.0% (2/5) vs. 11.8% (2/17), p = 0.209] cancers.